Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.365 USD | +3.03% |
|
-12.85% | +51.64% |
| Market Cap | 320M 428M 375M 348M 605M 40.97B 617M 4.14B 1.63B 20.12B 1.61B 1.57B 69.48B | P/E 2026 * |
-15.2x | P/E 2027 * | -13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 173M 232M 204M 189M 328M 22.22B 335M 2.25B 881M 10.91B 872M 853M 37.68B | EV / Sales 2026 * |
69.5x | EV / Sales 2027 * | 20.5x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +3.14% | ||
| 1 week | -12.85% | ||
| Current month | -16.03% | ||
| 1 month | +31.71% | ||
| 3 months | +53.54% | ||
| 6 months | +56.01% | ||
| Current year | +51.64% |
| 1 week | 8.91 |  | 11 |
| 1 month | 6.52 | | 11.06 |
| Current year | 4.19 | | 11.06 |
| 1 year | 4.19 | | 11.06 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-06 | Sell | 865,112 | 0.6105% | |||
| 01-02 | Free | Director | 90,000 | 0.0635% | ||
| 01-02 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.03% | -12.85% | +46.82% | +54.44% | 429M | |
| +0.44% | +1.41% | +4.25% | +10.81% | 50.73B | |
| -1.67% | -4.33% | +373.70% | +585.11% | 39.73B | |
| +0.01% | +1.07% | +30.00% | -5.22% | 34.69B | |
| +1.98% | -1.91% | +20.39% | +53.18% | 33.21B | |
| -0.06% | -4.63% | +2.94% | +31.65% | 26.76B | |
| -1.91% | -1.46% | - | - | 16.8B | |
| -1.50% | -6.12% | +65.60% | +120.67% | 15.37B | |
| +0.78% | +1.16% | +15.53% | +17.32% | 13.78B | |
| -0.64% | -3.00% | +10.89% | -33.41% | 12.85B | |
| Average | +0.06% | -2.13% | +63.35% | +92.73% | 24.43B | |
| Weighted average by Cap. | -0.14% | -0.40% | +80.17% | +122.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.5M 3.34M 2.93M 2.71M 4.72M 320M 4.81M 32.32M 12.68M 157M 12.54M 12.26M 542M | 3.44M 4.6M 4.04M 3.74M 6.51M 441M 6.63M 44.57M 17.48M 216M 17.29M 16.91M 747M |
| Net income | -50.34M -67.35M -59.07M -54.71M -95.22M -6.45B -97.07M -652M -256M -3.17B -253M -247M -10.93B | -84.67M -113M -99.35M -92.02M -160M -10.84B -163M -1.1B -430M -5.32B -425M -416M -18.39B |
| Net Debt | -146M -196M -172M -159M -277M -18.75B -282M -1.9B -744M -9.21B -736M -720M -31.8B | -249M -334M -293M -271M -472M -31.94B -481M -3.23B -1.27B -15.68B -1.25B -1.23B -54.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | $9.220 | +1.43% | 167,056 |
| 10/07/26 | $9.090 | -7.81% | 365,407 |
| 09/07/26 | $9.860 | -0.90% | 232,796 |
| 08/07/26 | $9.950 | -1.97% | 494,240 |
| 07/07/26 | $10.15 | -4.06% | 617,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
